Concepedia

Osamu Shimozato

OS

Statistics

Publications

48

Citations

1.9K

H-Index

25

Active since

1996

Affiliations

Chiba Cancer Center(Current)

Chiba University

Juntendo University

Frederick National Laboratory for Cancer Research

The University of Tokyo

Osamu Shimozato is an author at Chiba Cancer Center specializing in life sciences, immunology, and oncology.

ORCID

Publications per year

1996–2022

48

Publications

48

Perforin-dependent NK cell cytotoxicity is sufficient for anti-metastatic effect of IL-12

Tomohiro Kodama, Kazuyoshi Takeda, Osamu Shimozato et al. · European Journal of Immunology · 1999 · 153 citations

, , +16

CD133 suppresses neuroblastoma cell differentiation via signal pathway modification

Hisanori Takenobu, Osamu Shimozato, Takafumi Nakamura et al. · Oncogene · 2010 · 128 citations

, , +11

Expression of IL‐27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals

Masako Chiyo, Osamu Shimozato, Ling Yu et al. · International Journal of Cancer · 2005 · 124 citations

, , +16

Local production of the p40 subunit of interleukin 12 suppresses T-helper 1-mediated immune responses and prevents allogeneic myoblast rejection.

Kazunori Kato, Osamu Shimozato, Kazuto Hoshi et al. · Proceedings of the National Academy of Sciences · 1996 · 100 citations

, , +17

Regulation of tumour necrosis factor‐related apoptosis‐inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils

Hidenobu Kamohara, Wataru Matsuyama, Osamu Shimozato et al. · Immunology · 2004 · 84 citations · Full text

, , +17

1–5 of 48